Golisano Children’s Hospital Earns Funding from NICHD Neonatal Research Network
The Neonatology Division
at Golisano Children’s Hospital
has been renewed for its second consecutive stint as a part of National Institute of Child Health and Human Development (NICHD) Neonatal Research Network
. URMC, in partnership with University at Buffalo
, received $1.2 million from the NICHD and is one of just 15 major U.S. intensive care units that belong to the Network. The mission of the Network is to join hospitals together to answer questions about the health of newborn babies that cannot be answered by one hospital alone.
“The Network is a highly competitive, respected collaborative that performs clinical trials in newborns,” said Carl D’Angio, M.D., chief of the Neonatology Division at Golisano Children’s Hospital and principal investigator. “Our joint partnership with University at Buffalo makes clinical trials available to children across Western New York.”
This collaboration also gives URMC a competitive edge for other funding as well. Recently, URMC completed a Prematurity and Respiratory Outcomes Program funded by an NIH grant. Additionally, a relationship with University at Buffalo means improved communication between our neonatologists and theirs.
The numerous studies being performed at UR Medicine include:
“Being renewed means that we are recognized as one of the premier neonatal research institutions in the country,” D’Angio said. “It’s a competitive process—we re-compete every 5 years, and not everyone gets to be back in. It says something about the quality of the research here and I am very proud of the folks who are involved.”
Over 1,200 infants with a broad range of neonatal problems are admitted to the Level IV NICU at Golisano Children’s Hospital each year.
In 1986, the Eunice Kennedy Shriver NICHD of the National Institutes of Health initiated the Neonatal Research Network. This network was established to conduct multi-center clinical trials and observational studies in neonatal medicine in order to reduce infant morbidity and mortality while promoting healthy outcomes.